IRIS Accounts Production v25.1.3.33 06723673 Board of Directors 31.12.24 1.1.24 31.12.24 31.12.24 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Manufacturer of cosmetic skincare and haircare products. true true false true true false false false true false A Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067236732023-12-31067236732024-12-31067236732024-01-012024-12-31067236732022-12-31067236732023-01-012023-12-31067236732023-12-3106723673ns15:EnglandWales2024-01-012024-12-3106723673ns14:PoundSterling2024-01-012024-12-3106723673ns10:Director12024-01-012024-12-3106723673ns10:Consolidated2024-12-3106723673ns10:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3106723673ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3106723673ns10:Consolidatedns10:MediumEntities2024-01-012024-12-3106723673ns10:Consolidatedns10:Audited2024-01-012024-12-3106723673ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3106723673ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3106723673ns10:Consolidated2024-01-012024-12-3106723673ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3106723673ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3106723673ns10:FullAccounts2024-01-012024-12-310672367312024-01-012024-12-3106723673ns10:OrdinaryShareClass12024-01-012024-12-3106723673ns10:Director22024-01-012024-12-3106723673ns10:RegisteredOffice2024-01-012024-12-3106723673ns10:Consolidated2023-01-012023-12-3106723673ns5:CurrentFinancialInstruments2024-12-3106723673ns5:CurrentFinancialInstruments2023-12-3106723673ns5:Non-currentFinancialInstruments2024-12-3106723673ns5:Non-currentFinancialInstruments2023-12-3106723673ns5:ShareCapital2024-12-3106723673ns5:ShareCapital2023-12-3106723673ns5:SharePremium2024-12-3106723673ns5:SharePremium2023-12-3106723673ns5:CapitalRedemptionReserve2024-12-3106723673ns5:CapitalRedemptionReserve2023-12-3106723673ns5:RetainedEarningsAccumulatedLosses2024-12-3106723673ns5:RetainedEarningsAccumulatedLosses2023-12-3106723673ns5:ShareCapital2022-12-3106723673ns5:RetainedEarningsAccumulatedLosses2022-12-3106723673ns5:SharePremium2022-12-3106723673ns5:CapitalRedemptionReserve2022-12-3106723673ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3106723673ns5:CapitalRedemptionReserve2023-01-012023-12-3106723673ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3106723673ns5:CapitalRedemptionReserve2024-01-012024-12-310672367312024-01-012024-12-3106723673ns5:NetGoodwill2024-01-012024-12-3106723673ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106723673ns5:LeaseholdImprovements2024-01-012024-12-3106723673ns5:PlantMachinery2024-01-012024-12-3106723673ns5:FurnitureFittings2024-01-012024-12-3106723673ns5:MotorVehicles2024-01-012024-12-3106723673ns5:NetGoodwill2023-12-3106723673ns5:NetGoodwill2024-12-3106723673ns5:NetGoodwill2023-12-3106723673ns5:LeaseholdImprovements2023-12-3106723673ns5:PlantMachinery2023-12-3106723673ns5:FurnitureFittings2023-12-3106723673ns5:MotorVehicles2023-12-3106723673ns5:LeaseholdImprovements2024-12-3106723673ns5:PlantMachinery2024-12-3106723673ns5:FurnitureFittings2024-12-3106723673ns5:MotorVehicles2024-12-3106723673ns5:LeaseholdImprovements2023-12-3106723673ns5:PlantMachinery2023-12-3106723673ns5:FurnitureFittings2023-12-3106723673ns5:MotorVehicles2023-12-3106723673ns5:CostValuation2023-12-3106723673ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106723673ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3106723673ns5:AcceleratedTaxDepreciationDeferredTax2024-12-3106723673ns5:AcceleratedTaxDepreciationDeferredTax2023-12-3106723673ns5:TaxLossesCarry-forwardsDeferredTax2024-12-3106723673ns5:TaxLossesCarry-forwardsDeferredTax2023-12-3106723673ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-12-3106723673ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-12-3106723673ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3106723673ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3106723673ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-12-3106723673ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-12-3106723673ns5:HirePurchaseContracts2024-12-3106723673ns5:HirePurchaseContracts2023-12-3106723673ns5:WithinOneYear2024-12-3106723673ns5:WithinOneYear2023-12-3106723673ns5:BetweenOneFiveYears2024-12-3106723673ns5:BetweenOneFiveYears2023-12-3106723673ns5:MoreThanFiveYears2024-12-3106723673ns5:MoreThanFiveYears2023-12-3106723673ns5:AllPeriods2024-12-3106723673ns5:AllPeriods2023-12-3106723673ns5:Secured2024-12-3106723673ns5:Secured2023-12-3106723673ns5:DeferredTaxation2023-12-3106723673ns5:DeferredTaxation2024-01-012024-12-3106723673ns5:DeferredTaxation2024-12-3106723673ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 06723673 (England and Wales)















Orean Personal Care Limited

Group Strategic Report, Report of the Directors and

Consolidated Financial Statements

For The Year Ended 31 December 2024






Orean Personal Care Limited (Registered number: 06723673)






Contents of the Consolidated Financial Statements
For The Year Ended 31 December 2024




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Consolidated Income Statement 10

Consolidated Other Comprehensive Income 11

Consolidated Balance Sheet 12

Company Balance Sheet 13

Consolidated Statement of Changes in Equity 14

Company Statement of Changes in Equity 15

Consolidated Cash Flow Statement 16

Notes to the Consolidated Cash Flow Statement 17

Notes to the Consolidated Financial Statements 18


Orean Personal Care Limited

Company Information
For The Year Ended 31 December 2024







DIRECTORS: D M Williams
M Crossley





REGISTERED OFFICE: Unit E1
Stubs Beck Lane
West 26 Industrial Estate
Cleckheaton
South Yorkshire
BD19 4TT





REGISTERED NUMBER: 06723673 (England and Wales)





AUDITORS: Roddis Taylor Robinson
Chartered Accountants
Statutory Auditor
Unit 6, Acorn Business Park
Woodseats Close
Sheffield
South Yorkshire
S8 0TB

Orean Personal Care Limited (Registered number: 06723673)

Group Strategic Report
For The Year Ended 31 December 2024

The directors present their strategic report of the company and the group for the year ended 31 December 2024.

REVIEW OF BUSINESS
Orean Personal Care Limited and its wholly owned subsidiary, Orean Beauty Inc area contract manufacturers of cosmetic and haircare products.

Despite a strong order book throughout the year of 2024, the last quarter proved very challenging as many brands pushed orders out into 2025, due to cashflow challenges and stock holding levels. A similar pattern to what was seen in 2023. Due to the level of customers that supply their own packaging, there was little that could be done to convert the sales orders into stock for sale. As a business the group continues to discuss and work through creative solution with its brand partners to ensure that there are solutions that work for both parties. This is testament to the strength of the partnerships that the group has with its customers.

One of the biggest challenges faced in 2024 was cashflow. This was largely driven by one brand partner who, at its peak was £3million overdue. All group suppliers were phenomenally supportive, and this issue was resolved by the end of the year. Again, the strength of the groups relationships was evident here and the group maintained dialogue between all parties.

The volatility of the supply chain continued to make planning challenging, and the group continues to remain as flexible as possible, ensuring it can maximise monthly sales and ensure that it reacts to customers' demands as efficiently as it can.

Another challenge during 2024 arose from a significant brand that the group had manufactured for more than 12 years being bought by another manufacturer. The group therefore spent the year phasing the move of orders to this manufacturer.

Despite these challenges, the sales in the UK increased 20% on 2023 with similar growth in the US.

The group continues to invest and support the US site with its indirect functions in the UK. This allows the group to support its UK partners with growth in this market, navigating tariff challenges, reducing leadtimes and freight costs and exposing them to new opportunities. The group is now starting to work with established and US native brands.

The future strategy is to continue this growth throughout 2025 in both the UK and US sites, with established brands in both markets approaching the group for both new business and the transfer of existing products.

The group continues to be open with its strategy and share its ambitions with staff members, brand partners and suppliers. This is well received and is very much reflective of their own ambition.

The group continues to focus on making full-service projects more appealing to customers which in turn will provide the group with greater control of its production plan, however, this will consume more cash up front.

PRINCIPAL RISKS AND UNCERTAINTIES
Supply Chain challenges continue to be an issue and over several years as the group has been impacted by cost of living crisis, a pandemic, war in Europe, the Suez Canal challenge and Brexit amongst other things

The group held firm with the strategic decision to not pass on cost increases to customers. This decision was not made lightly; however, it was made at board level in order to protect existing business and ensure brands could continue to flourish and avoid potential delists with retailers. Management continue to review options to mitigate increases where possible through purchasing and operational efficiencies.

Due to the volume of sales that were pushed backed, the group's earnings suffered as overheads were tracking at a level that would support a greater level of budgeted sales. The purchase orders were received, however demand was delayed.

This affected both the group's stock holding and gross margin, but management are confident that this will start to readjust itself in the next couple of years.


Orean Personal Care Limited (Registered number: 06723673)

Group Strategic Report
For The Year Ended 31 December 2024


STREAMLINED ENERGY AND CARBON REPORTING
In line with the Companies (Directors' Report) and Limited Liability Partnerships (Energy and Carbon Report) Regulations 2018 the company's energy use and greenhouse gas(GHG) emissions are set out below.

The data relates to UK emissions for the 12 month period from 1 January 2024 to 31 December 2024.

Orean Personal Care Limited Energy Use and Associated Greenhouse Gas Emissions
YE 2024 YE 2023
Total Energy consumption (kWh) 1,500,104 1,153,124
Emissions from combustion of gas (Scope 1) (tCO2e) 103 73
Emissions from transport (Scope 1) (tCO2e) 9 9
Emissions from purchased electricity (Scope 2) (tCO2e) 149 111
Emissions from business travel in employee-owned vehicles where the company's
responsible for purchasing the fuel or electricity (Scope 3) (tCO2e)

7

N/A
Total Gross emissions (tCO2e) 268 193
tCO2e per £m turnover 9 8
Renewable Energy generated and then used onsite (kWh) 150,216 181,808
Emissions avoided by renewable energy generated and then used onsite (tCO2e) 31 38
Emissions avoided by purchasing renewable electricity (tCO2e) 0 24
Total annual net emissions (tCO2e) 268 169

Quantification and Reporting Methodology:

The boundaries of this report are based on operational control. The company reports it emissions with reference to the latest Greenhouse Gas Protocol Corporate Accounting and Reporting Standard (GHG Protocol). In accordance with the 2018 Regulations, the energy use and associated greenhouse gas emissions are for those within the UK only that come under the operational control boundary. Therefore, energy use and emissions are aligned with financial reporting for the UK entity and exclude the non-UK based subsidiaries that would not qualify under the 2018 Regulations in their own right. The 2024 UK Government GHG Conversion Factors for Company Reporting published by the Department for Energy Security and Net Zero are used to convert energy use in our operations to emissions of CO2e. Carbon emission factors for purchased electricity calculated according to the 'location-based grid average' method. This reflects the average emission of the grid where the energy consumption occurs. Data sources include billing, invoices and internal systems. For transport data where actual usage data (e.g. litres) was unavailable conversions were made using average fuel consumption factors to estimate the usage. Gas consumption at the Low Moor site was unavailable for Q4, as such this was estimated.

Intensity Ratio

The company has chosen to report its gross emissions against a financial metric of tCO2e per £m Turnover, in 2024 our Turnover was £30 million, therefore the ratio is 9 tCO2e/£m Turnover.

Energy Efficiency Action

Installed Solar panels on the Warehouse roof at Low Moor site, energy generated is used on-site. The company is continuing to investigate the investment in additional solar and the storage/use of the electricity generated.

Due to the location of the manufacturing site at Stubs Beck Lane and the close proximity to the M62, the solar panels had got very dirty since they were installed which resulted in a significant drop off in generation of electricity. These have now been cleaned and a cleaning plan established and put in place.

During the 2024 reporting period the company added some lagging on its production chilled water tank to reduce the amount of electricity used to power the chiller.


Orean Personal Care Limited (Registered number: 06723673)

Group Strategic Report
For The Year Ended 31 December 2024

DEVELOPMENT AND PERFORMANCE
One of group's key objectives moving forward is to deliver the order book as smoothly as possible by planning production activities effectively. This should reduce the pressures within the business by keeping periods of extreme volume to a minimum. There's also a keen focus on health and safety, training and efficiencies.

The bespoke ERP system that is being developed, has evolved to and this will now be rolled at through the Q3/Q4 2025. This is to improve efficiencies across the business and reduce the reliance on additional employees as the group grows, to maintain overheads while maintaining the group's flexibility and unique, agile approach to manufacturing across both the UK and US sites.

The sourcing of US materials has increased dramatically and is now tracking at 65% and growing. This provides customers with reduced leadtimes and flexibility and keeps stock holding to a minimum. Despite this increase this will never be at 100% as the group will continue to maintain central purchasing in the UK to ensure that stock levels are effectively managed and cashflow relating to MOQ's of materials and ensure that the group benefits from economies of scale.

The group is now being approached by Brands in the US for production locally and in the US. This will allow the group to reduce the concentration around one key account.

KEY PERFORMANCE INDICATORS
Management continue to focus on labour as a % of revenue, stock holding both as a % of the 3 month forecast and also as a % of total order book. Management continue to ensure that cost of materials is maintained as a % of revenue while flexing where appropriate for strategic sales of lower margin products.

Debtors and Creditors are tracked monthly with a big focus on both supplier and customer relationships to ensure that we build and nurture long-term partnerships that all parties benefit from.

OTHER INFORMATION AND EXPLANATIONS
The group has an unrivalled reputation for flexibility within its industry, and it is crucial that this is preserved whilst trying to improve business processes. This has again been validated by an external consultant.

ON BEHALF OF THE BOARD:





D M Williams - Director


29 September 2025

Orean Personal Care Limited (Registered number: 06723673)

Report of the Directors
For The Year Ended 31 December 2024

The directors present their report with the financial statements of the company and the group for the year ended 31 December 2024.

DIVIDENDS
The directors do not recommend the payment of a dividend in respect of the year ended 31 December 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

D M Williams
M Crossley

The company has provided third party indemnity insurance cover for its Directors during the year ended 31 December 2024.

EMPLOYMENT OF DISABLED PERSONS
Disabled persons are employed by the group when they are suited to a particular vacancy and every effort is made to ensure that they are given full and fair consideration when such vacancies arise. Training is offered so that employees, who have been injured or become disabled in the course of their employment, can where possible, continue their employment with the group.

ENGAGEMENT WITH EMPLOYEES
The group's focus is on maintaining existing headcount and maintaining the level of investment around training and development, sustainability solutions and social impact support.

The Directors make employees aware of employment matters and the financial and economic factors affecting the group, through one to one meetings, newsletters and video briefings. They invite feedback informally and also through a formal employee suggestion process using a token method.

The group employs a dedicated Corporate Social Responsibility Officer which helps the group focus on supporting local charities, businesses and teams and has the Investors in People accreditation.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Orean Personal Care Limited (Registered number: 06723673)

Report of the Directors
For The Year Ended 31 December 2024


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

ON BEHALF OF THE BOARD:





D M Williams - Director


29 September 2025

Report of the Independent Auditors to the Members of
Orean Personal Care Limited

Opinion
We have audited the financial statements of Orean Personal Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2024 and of the group's loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Orean Personal Care Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:


Report of the Independent Auditors to the Members of
Orean Personal Care Limited

The Group is subject to laws and regulations that directly and indirectly affect the financial statements. Based on our understanding of the Group and the environment in which it operates, we determined that the laws and regulations which were most significant included Health and Safety, Environmental and the European Directive for Cosmetics. We considered the extent to which non-compliance with laws and regulations might have a material effect on the financial statements, including how fraud might occur. We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls) and determined that the principal risks related to the posting of inappropriate journal entries to manipulate the Group results for the year and management bias in key accounting estimates.

Audit procedures performed by the engagement team included:

- Discussions with management to obtain an understanding of the legal and regulatory framework applicable to the
group and how it ensures compliance, including consideration of known or suspected instances of
non-compliance with laws and regulations and fraud;

- Reviewing minutes of Board meetings;

- Identifying and assessing the effectiveness of internal controls in place to mitigate risks of fraud and
non-compliance with laws and regulations;

- Enquiring of management as to actual and potential litigation and claims and reviewing legal and professional
fees;

- Challenging assumptions and judgements made by management in their significant accounting estimates;

- Identifying and testing journal entries, in particular any journal entries posted with unusual account combinations
or posted by senior management.

There are inherent limitations in the audit procedures described above and the more removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentation or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Julie Holderness (Senior Statutory Auditor)
for and on behalf of Roddis Taylor Robinson
Chartered Accountants
Statutory Auditor
Unit 6, Acorn Business Park
Woodseats Close
Sheffield
South Yorkshire
S8 0TB

29 September 2025

Orean Personal Care Limited (Registered number: 06723673)

Consolidated
Income Statement
For The Year Ended 31 December 2024

2024 2023
Notes £    £   

TURNOVER 3 35,807,705 28,693,207

Cost of sales (31,265,313 ) (25,086,917 )
GROSS PROFIT 4,542,392 3,606,290

Administrative expenses (5,285,253 ) (4,546,525 )
(742,861 ) (940,235 )

Other operating income 290,754 254,142
OPERATING LOSS 5 (452,107 ) (686,093 )

Interest receivable and similar income - 4,679
(452,107 ) (681,414 )

Interest payable and similar expenses 6 (464,266 ) (314,451 )
LOSS BEFORE TAXATION (916,373 ) (995,865 )

Tax on loss 7 300,008 543,727
LOSS FOR THE FINANCIAL YEAR (616,365 ) (452,138 )
Loss attributable to:
Owners of the parent (616,365 ) (452,138 )

Orean Personal Care Limited (Registered number: 06723673)

Consolidated
Other Comprehensive Income
For The Year Ended 31 December 2024

2024 2023
Notes £    £   

LOSS FOR THE YEAR (616,365 ) (452,138 )


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(616,365

)

(452,138

)

Total comprehensive income attributable to:
Owners of the parent (616,365 ) (452,138 )

Orean Personal Care Limited (Registered number: 06723673)

Consolidated Balance Sheet
31 December 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 9 197,806 232,206
Tangible assets 10 3,669,955 3,869,963
Investments 11 - -
3,867,761 4,102,169

CURRENT ASSETS
Stocks 12 5,107,147 4,710,051
Debtors 13 8,284,085 8,001,384
Cash at bank and in hand 390,992 250,484
13,782,224 12,961,919
CREDITORS
Amounts falling due within one year 14 10,000,104 8,787,133
NET CURRENT ASSETS 3,782,120 4,174,786
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,649,881

8,276,955

CREDITORS
Amounts falling due after more than one
year

15

228,820

239,529
NET ASSETS 7,421,061 8,037,426

CAPITAL AND RESERVES
Called up share capital 20 1,193 1,193
Share premium 444,485 444,485
Capital redemption reserve 1,142 1,142
Retained earnings 6,974,241 7,590,606
SHAREHOLDERS' FUNDS 7,421,061 8,037,426

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





D M Williams - Director


Orean Personal Care Limited (Registered number: 06723673)

Company Balance Sheet
31 December 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 2,029,011 2,202,122
Investments 11 420,028 420,028
2,449,039 2,622,150

CURRENT ASSETS
Stocks 12 3,520,421 3,742,965
Debtors 13 10,059,714 9,546,224
Cash at bank and in hand 138,089 106,817
13,718,224 13,396,006
CREDITORS
Amounts falling due within one year 14 7,416,746 7,445,279
NET CURRENT ASSETS 6,301,478 5,950,727
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,750,517

8,572,877

CREDITORS
Amounts falling due after more than one
year

15

(228,820

)

(67,951

)

PROVISIONS FOR LIABILITIES 19 - (30,071 )
NET ASSETS 8,521,697 8,474,855

CAPITAL AND RESERVES
Called up share capital 20 1,193 1,193
Share premium 444,485 444,485
Capital redemption reserve 1,142 1,142
Retained earnings 8,074,877 8,028,035
SHAREHOLDERS' FUNDS 8,521,697 8,474,855

Company's profit/(loss) for the financial year 46,842 (479,144 )

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





D M Williams - Director


Orean Personal Care Limited (Registered number: 06723673)

Consolidated Statement of Changes in Equity
For The Year Ended 31 December 2024

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 January 2023 1,193 8,042,744 444,485 1,142 8,489,564

Changes in equity
Total comprehensive income - (452,138 ) - - (452,138 )
Balance at 31 December 2023 1,193 7,590,606 444,485 1,142 8,037,426

Changes in equity
Total comprehensive income - (616,365 ) - - (616,365 )
Balance at 31 December 2024 1,193 6,974,241 444,485 1,142 7,421,061

Orean Personal Care Limited (Registered number: 06723673)

Company Statement of Changes in Equity
For The Year Ended 31 December 2024

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 January 2023 1,193 8,507,179 444,485 1,142 8,953,999

Changes in equity
Total comprehensive income - (479,144 ) - - (479,144 )
Balance at 31 December 2023 1,193 8,028,035 444,485 1,142 8,474,855

Changes in equity
Total comprehensive income - 46,842 - - 46,842
Balance at 31 December 2024 1,193 8,074,877 444,485 1,142 8,521,697

Orean Personal Care Limited (Registered number: 06723673)

Consolidated Cash Flow Statement
For The Year Ended 31 December 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 480,658 2,855,527
Interest paid (464,266 ) (314,451 )
Tax paid (6,135 ) (160,200 )
Exchange differences 1,950 56,058
Net cash from operating activities 12,207 2,436,934

Cash flows from investing activities
Purchase of tangible fixed assets (937,113 ) (1,027,191 )
Sale of tangible fixed assets - 25,000
Interest received - 4,679
Net cash from investing activities (937,113 ) (997,512 )

Cash flows from financing activities
New loans in year net of repayments 796,725 -
Loan repayments in year - (1,588,875 )
New finance leases net of repayments 268,689 (8,799 )
Net cash from financing activities 1,065,414 (1,597,674 )

Increase/(decrease) in cash and cash equivalents 140,508 (158,252 )
Cash and cash equivalents at beginning of
year

2

250,484

408,736

Cash and cash equivalents at end of year 2 390,992 250,484

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Cash Flow Statement
For The Year Ended 31 December 2024

1. RECONCILIATION OF LOSS BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2024 2023
£    £   
Loss before taxation (916,373 ) (995,865 )
Depreciation charges 1,169,571 1,061,315
Profit on disposal of fixed assets - (25,000 )
Government grants (9,807 ) (10,774 )
Finance costs 464,266 314,451
Finance income - (4,679 )
707,657 339,448
(Increase)/decrease in stocks (397,096 ) 222,233
Decrease in trade and other debtors 37,398 3,110,232
Increase/(decrease) in trade and other creditors 132,699 (816,386 )
Cash generated from operations 480,658 2,855,527

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 390,992 250,484
Year ended 31 December 2023
31.12.23 1.1.23
£    £   
Cash and cash equivalents 250,484 408,736


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.24 Cash flow At 31.12.24
£    £    £   
Net cash
Cash at bank and in hand 250,484 140,508 390,992
250,484 140,508 390,992
Debt
Finance leases - (268,689 ) (268,689 )
Debts falling due within 1 year (711,023 ) (1,017,247 ) (1,728,270 )
Debts falling due after 1 year (220,522 ) 220,522 -
(931,545 ) (1,065,414 ) (1,996,959 )
Total (681,061 ) (924,906 ) (1,605,967 )

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements
For The Year Ended 31 December 2024

1. STATUTORY INFORMATION

Orean Personal Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going Concern
After due consideration of all relevant factors, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and accounts.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts recorded for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The estimates and underlying assumptions are reviewed on an ongoing basis and any revisions to them are recognised in the period in which they are revised.

The estimates and assumptions that have a significant risk of causing material adjustment to the carrying amount of assets and liabilities within the next financial year are addressed below:

i. Useful economic lives of tangible assets

The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 10 for the carrying amount of tangible assets.

ii. Stock provisioning

The company manufactures a range of cosmetic products for its customers, which are subject to changing consumer demands and fashion trends. As a result, it is necessary to consider the recoverability of the cost of stock and the associated provisioning required. When calculating the stock provision, management consider the nature and condition of the stock, as well as applying assumptions around anticipated saleability of finished goods and future usage of raw materials. See note 12 for the net carrying amount of stock.

iii. Impairment of debtors

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current rating of the debtor, the ageing profile of debtors and historical experience. See note 13 for the net carrying amount of trade and other debtors.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover from product sales is recognised upon delivery to the customer.

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2020, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Improvements to property - 10% straight line
Plant and machinery - 20% straight line
Fixtures and fittings - 33% straight line and 10% straight line
Motor vehicles - 33% straight line

Tangible assets are stated at cost less accumulated depreciation.

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Financial instruments
Basic financial assets
Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at the transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

At the end of each accounting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.

Basic financial liabilities
Basic financial liabilities, including trade and other creditors and bank loans are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
For individual companies within the group, transaction denominated in foreign currencies are translated into the local currency using the exchange rate ruling at the date of the transaction. Assets and liabilities denominated in a foreign currency have been translated into the local currency at the year end rate. Realised foreign exchange differences are taken to the profit and loss account.

On consolidation the profit and loss accounts of foreign subsidiaries are translated into sterling at the average exchange rate for the accounting period and assets and liabilities are translated at the year end rate. Any exchange difference arising on consolidation is taken to the profit and loss account.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and loss before taxation are attributable to the one principal activity of the group.

An analysis of turnover by geographical market is given below:

2024 2023
£    £   
United Kingdom 27,487,164 21,422,747
United States of America 8,320,541 7,270,460
35,807,705 28,693,207

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

4. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 9,583,569 7,639,881
Social security costs 848,325 703,773
Other pension costs 643,171 568,900
11,075,065 8,912,554

The average number of employees during the year was as follows:
2024 2023

Direct 253 222
Indirect 34 34
Directors 2 2
289 258

2024 2023
£    £   
Directors' remuneration 214,732 201,859

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 2 2

Information regarding the highest paid director is as follows:
2024 2023
£    £   
Emoluments etc 124,226 118,678

Company pension contributions to money purchase schemes for the directors amounted to £23,471 (2023: £22,281).

5. OPERATING LOSS

The operating loss is stated after charging/(crediting):

2024 2023
£    £   
Hire of plant and machinery 303,157 260,771
Depreciation - owned assets 1,090,317 1,026,915
Depreciation - assets on hire purchase contracts 44,854 -
Profit on disposal of fixed assets - (25,000 )
Goodwill amortisation 34,400 34,400
Auditors' remuneration 18,585 17,700
Auditors' remuneration for non audit work 5,415 7,695
Rent on leased property 944,138 830,562

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank loan interest 46,879 73,548
Other interest payable 417,387 240,903
464,266 314,451

7. TAXATION

Analysis of the tax credit
The tax credit on the loss for the year was as follows:
2024 2023
£    £   
Current tax:
Foreign tax 20,091 -

Deferred tax (320,099 ) (543,727 )
Tax on loss (300,008 ) (543,727 )

Reconciliation of total tax credit included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Loss before tax (916,373 ) (995,865 )
Loss multiplied by the standard rate of corporation tax in the UK of 25 %
(2023 - 25 %)

(229,093

)

(248,966

)

Effects of:
Expenses not deductible for tax purposes 54,733 93,497
Adjustments to tax charge in respect of previous periods 26,080 13,373
Other reliefs (174,660 ) (424,388 )
Depreciation and amortisation on assets not eligible for capital allowances 22,932 22,757
Total tax credit (300,008 ) (543,727 )

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

9. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 January 2024
and 31 December 2024 729,370
AMORTISATION
At 1 January 2024 497,164
Amortisation for year 34,400
At 31 December 2024 531,564
NET BOOK VALUE
At 31 December 2024 197,806
At 31 December 2023 232,206

Company
Goodwill
£   
COST
At 1 January 2024
and 31 December 2024 385,364
AMORTISATION
At 1 January 2024
and 31 December 2024 385,364
NET BOOK VALUE
At 31 December 2024 -
At 31 December 2023 -

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

10. TANGIBLE FIXED ASSETS

Group
Improvements Fixtures
to Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 January 2024 512,256 5,588,402 2,044,244 75,979 8,220,881
Additions - 845,231 91,882 - 937,113
Exchange differences - 3,643 567 29 4,239
At 31 December 2024 512,256 6,437,276 2,136,693 76,008 9,162,233
DEPRECIATION
At 1 January 2024 283,261 3,168,159 833,257 66,241 4,350,918
Charge for year 47,774 888,985 190,211 8,201 1,135,171
Exchange differences - 5,694 436 59 6,189
At 31 December 2024 331,035 4,062,838 1,023,904 74,501 5,492,278
NET BOOK VALUE
At 31 December 2024 181,221 2,374,438 1,112,789 1,507 3,669,955
At 31 December 2023 228,995 2,420,243 1,210,987 9,738 3,869,963

The net book value of tangible fixed assets includes £ 265,746 in respect of assets held under hire purchase contracts.

Company
Improvements Fixtures
to Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 January 2024 512,256 3,577,280 1,727,457 59,790 5,876,783
Additions - 386,192 73,210 - 459,402
At 31 December 2024 512,256 3,963,472 1,800,667 59,790 6,336,185
DEPRECIATION
At 1 January 2024 283,261 2,551,606 784,587 55,207 3,674,661
Charge for year 47,774 421,737 158,419 4,583 632,513
At 31 December 2024 331,035 2,973,343 943,006 59,790 4,307,174
NET BOOK VALUE
At 31 December 2024 181,221 990,129 857,661 - 2,029,011
At 31 December 2023 228,995 1,025,674 942,870 4,583 2,202,122

The net book value of tangible fixed assets includes £ 265,746 in respect of assets held under hire purchase contracts.

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 January 2024
and 31 December 2024 420,028
NET BOOK VALUE
At 31 December 2024 420,028
At 31 December 2023 420,028

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries


Orean Inc
Registered office: USA
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Orean Beauty Inc
Registered office: USA
Nature of business: Manufacturer of skincare and haircare products
%
Class of shares: holding
Ordinary 100.00


12. STOCKS

Group Company
2024 2023 2024 2023
£    £    £    £   
Raw materials 4,548,055 3,848,256 3,140,770 3,059,401
Work-in-progress 192,287 465,533 159,942 300,813
Finished goods 366,805 396,262 219,709 382,751
5,107,147 4,710,051 3,520,421 3,742,965

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Trade debtors 7,136,174 7,329,095 4,932,992 5,601,193
Amounts owed by group undertakings - - 4,507,665 3,586,303
Other debtors 156,333 185,223 156,333 161,028
Deferred tax asset 426,490 106,391 194,699 -
Prepayments and accrued income 565,088 380,675 268,025 197,700
8,284,085 8,001,384 10,059,714 9,546,224

Deferred tax asset
Group Company
2024 2023 2024 2023
£    £    £    £   
Accelerated capital allowances (559,646 ) (448,196 ) (389,714 ) -
Tax losses carried forward 983,906 550,904 582,183 -
Other timing differences 2,230 3,683 2,230 -
426,490 106,391 194,699 -

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans and overdrafts (see note 16) 1,728,270 711,023 65,132 189,964
Hire purchase contracts (see note 17) 49,069 - 49,069 -
Trade creditors 2,740,094 2,338,640 2,614,740 2,210,448
Tax 13,956 - - -
Social security and other taxes 142,340 140,982 142,340 140,982
VAT 624,181 379,478 624,181 379,478
Other creditors 2,993,883 3,576,958 2,993,883 3,576,958
Accrued expenses 1,697,504 1,629,245 916,594 936,642
Deferred government grants 10,807 10,807 10,807 10,807
10,000,104 8,787,133 7,416,746 7,445,279

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans (see note 16) - 220,522 - 48,944
Hire purchase contracts (see note 17) 219,620 - 219,620 -
Deferred government grants 9,200 19,007 9,200 19,007
228,820 239,529 228,820 67,951

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

16. LOANS

An analysis of the maturity of loans is given below:

Group Company
2024 2023 2024 2023
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 1,728,270 711,023 65,132 189,964
Amounts falling due between one and two years:
Bank loans - 1-2 years - 220,522 - 48,944

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 49,069 -
Between one and five years 219,620 -
268,689 -

Company
Hire purchase contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 49,069 -
Between one and five years 219,620 -
268,689 -

Group
Non-cancellable operating leases
2024 2023
£    £   
Within one year 717,020 889,669
Between one and five years 1,635,899 2,137,861
In more than five years 10,025 152,406
2,362,944 3,179,936

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

17. LEASING AGREEMENTS - continued

Company
Non-cancellable operating leases
2024 2023
£    £   
Within one year 329,158 513,834
Between one and five years 255,763 518,314
In more than five years 10,025 7,098
594,946 1,039,246

18. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans 1,728,270 931,545 65,132 238,908
Hire purchase contracts 268,689 - 268,689 -
Trade finance facility 2,946,075 3,576,958 2,946,075 3,576,958
4,943,034 4,508,503 3,279,896 3,815,866

Hire purchase liabilities are secured on the underlying fixed assets.

The trade finance facility is secured by a legal charge over trade debtors.

The company's bank loan is secured by a fixed and floating charge over the company's assets.

Group bank loans include an amount of £1,663,138 (2023: £692,637) which is secured by a legal charge over the fixed assets located in the USA and a corporate guarantee from Orean Personal Care Limited.

19. PROVISIONS FOR LIABILITIES

Company
2024 2023
£    £   
Deferred tax
Accelerated capital allowances - 407,763
Tax losses carried forward - (374,009 )
Other timing differences - (3,683 )
- 30,071

Group
Deferred
tax
£   
Balance at 1 January 2024 (106,391 )
Provided during year (320,099 )
Balance at 31 December 2024 (426,490 )

Orean Personal Care Limited (Registered number: 06723673)

Notes to the Consolidated Financial Statements - continued
For The Year Ended 31 December 2024

19. PROVISIONS FOR LIABILITIES - continued

Company
Deferred
tax
£   
Balance at 1 January 2024 30,071
Provided during year (224,770 )
Balance at 31 December 2024 (194,699 )

20. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,193 A Ordinary £1 1,193 1,193

21. CAPITAL COMMITMENTS
2024 2023
£    £   
Contracted but not provided for in the
financial statements 14,670 207,050

22. RELATED PARTY DISCLOSURES

Other related parties
2024 2023
£    £   
Purchases 387,479 365,796
Amount due to related party 96,230 -

The group rents premises from the pension scheme of one of the shareholders. The group also buys services from a company in which one of the shareholders has an interest.